Key result
Intracardiac NOS3 gene transfer in immunized pigs resulted in 200-fold greater median reporter transgene expression in the subendocardium compared to control virus coinfusion (P=0.02).
Why the study?
Does NOS3 gene transfer improve adenoviral-mediated myocardial gene expression and reduce inflammation in pigs with preexisting antiadenoviral immunity?
Population
Naive pigs and pigs immunized by intravenous injection of control virus AdRR5.
Comparison
Infusion of adenoviral vectors expressing human… vs Infusion of AdLuc alone, or coinfusion of AdLuc…
Design
Preclinical
Follow-up
3 days
Authors
Loading...
Supports testing NOS3 co-delivery to boost gene therapy in immunized hosts; hypothesis-generating for human translation.
Does NOS3 gene transfer improve adenoviral-mediated myocardial gene expression and reduce inflammation in pigs with preexisting antiadenoviral immunity?
Effect estimate: 200-fold greater
Absolute Event Rate: 1000% vs 45%
p-value: p=0.02
Intracardiac NOS3 gene transfer can overcome the barrier of preexisting antiadenoviral immunity, improving myocardial gene expression and reducing inflammation and apoptosis in a porcine model.
Szelid et al. (2002) studied Preexisting antiadenoviral immunity. AdNOS3 gene transfer vs. AdLuc and AdRR5 co-infection was evaluated on Median reporter transgene expression levels in the subendocardium (200-fold greater, p=0.02). Intracardiac NOS3 gene transfer in immunized pigs resulted in 200-fold greater median reporter transgene expression in the subendocardium compared to control virus coinfusion (P=0.02).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: